text_logo
logo
new_logo
cut_up

At Virginia Cancer Institute, we provide treatment, support, and follow-up care for people with cancer and blood disorders. Our purpose is to provide our patients with care that includes efficiency and compassion. The Virginia Cancer Institute is committed to offering care in an atmosphere of professionalism, encouragement, and understanding. Virginia Cancer Institute serves you by offering the best treatment plans, answering questions to your satisfaction, and respecting your informed decisions.

Virginia Cancer Institute's mission is to deliver high-quality, comprehensive medical care while maintaining our patients' quality of life. We offer a team approach for your cancer treatment by involving experts in medical oncology, hematology, chemotherapy, and clinical research.

The goal of our Web site is to:

  • Provide information about our programs, special services, physicians, and other health care professionals.
  • Help you understand your diagnosis and treatment choices.
  • Keep you focused on your quality of life.

We strive to promote respect, understanding, honesty, compassion, integrity, teamwork, individuality, and confidentiality at all times. We will remain committed to our purpose by remaining innovative and continuously increasing our awareness of technological advancements and the latest treatment methods. The physicians and staff continue to strive to remain dedicated to this mission.

Virginia Cancer Institute is dedicated to understanding the causes, prevention, and detection of cancer and to improving the quality of life for individuals living with cancer. Virginia Cancer Institute strives to be in the forefront of modern cancer care through the thoughtful introduction of promising new methods of treatment, the active participation in clinical research, the recruitment, development and education of highly trained oncology personnel, and the use of state-of-the art medical equipment.

cut_bottom
Latest Cancer News

BRCA Mutations Influence Ovarian Cancer Outcomes (01-27-2012)

Among women with ovarian cancer, those who have a BRCA1 or BRCA2 gene mutation appear to have better overall survival than those who do not have a BRCA gene mutation. These results were published in the Journal of the American Medical Association. Inherited... Continue Reading

Drug May Delay Need for Prostate Cancer Treatment (01-26-2012)

Among men who choose active surveillance for early-stage prostate cancer, Avodart® (dutasteride) may delay cancer progression and the need for cancer treatment. These results were published in The Lancet. The management of early prostate cancer may involve... Continue Reading

Abnormal Chromosome Influences Outcome of Rare Brain Tumor (01-25-2012)

For patients with uncommon brain tumors known as oligodendrogliomas, the presence of a specific chromosomal abnormality is linked with a better prognosis and responsiveness to chemotherapy. These results were released early (prior to presentation at an... Continue Reading